Walleye Capital’s GoodRx Holdings GDRX Stock Holding History

Walleye Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,700	Closed	-$126K	–	4750
2025 Q3	$126K	Sell	29,700 -100	-0.3%	-$440	﹤0.01%	3594
2025 Q2	$148K	Buy	+29,800	New	+$129K	﹤0.01%	3567
2024 Q4	–	Sell	-31,700	Closed	-$220K	–	5089
2024 Q3	$220K	Buy	+31,700	New	+$249K	﹤0.01%	3940

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Walleye Capital's GDRX Position: Q4 2025 in Review

Walleye Capital sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 27,519 shares — an estimated $116K sold.

Walleye Capital first reported a position in GDRX in Q2 2021 and held it in 10 quarters. The position peaked at $2.58M in Q2 2022. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

Walleye Capital reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 27,519 GoodRx Holdings shares in Q4 2025, an estimated $116K.
Walleye Capital first reported a position in GoodRx Holdings in Q2 2021 and held it in 10 quarters.
Walleye Capital's GoodRx Holdings position peaked at $2.58M in Q2 2022.
183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.